Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 26, 2007

View Archived Issues

Avexa reports progress with apricitabine

NovaCal changes name to NovaBay

Plethora seeks clearance to begin phase III for PSD-502 in premature ejaculation

TorreyPines and Eisai extend Alzheimer's disease collaboration

Peregrine licensee begins phase I trial with TNT cancer agent

New phase I trial studies L-annamycin in pediatric ALL and AML

CUV-1647 significantly delays onset of erythropoietic protoporphyria pain

Development of AOD-9604 in obesity terminated following phase IIb results

Antitumor activity following GVAX immunotherapy + ipilimumab

Incyte updates pipeline advances

Phase III findings for Cimzia in rheumatoid arthritis

CureDM reports diabetes preclinical milestones

Valeant files IND for Cesamet in chemotherapy-induced neuropathic pain

Rosiglitazone linked to increased incidence of fractures in female patients

Novel synthetic diazonamide A analogue shows promise in preclinical studies

Therapeutic potential for prolactin inhibition in postpartum cardiomyopathy

(-)-Epigallocatechin-3-gallate lipophilic analogue shows antidiabetic activity in vitro and in vivo

Roche suspends recruitment in phase II CERA study

Avastin recommended for approvals in Japan, E.U.

Approvable letter for Galvus

Vyvanse approved for ADHD

Xeloda recommended for E.U. approval for advanced gastric cancer

Sebivo recommended for approval in E.U. for chronic hepatitis B

Recent patents disclose novel antiinfective agents

Novel agents for HIV infection reported in recent patents

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...